Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Intralipid

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

  • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).


    The EU Clinical Trials Register currently displays   43881   clinical trials with a EudraCT protocol, of which   7295   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    15 result(s) found for: Intralipid. Displaying page 1 of 1.
    EudraCT Number: 2017-002936-17 Sponsor Protocol Number: LIV001 Start Date*: 2019-02-22
    Sponsor Name:Livio Falun
    Full Title: Treatment with intralipid in assisted fertilization
    Medical condition: Infertility conditions that required IVF treatment Male infertility Endometrosis PCOS uNEXPLAINED INFERTILITY Tubal damage
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: SE (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2011-002351-34 Sponsor Protocol Number: V1.0 Start Date*: 2013-02-21
    Sponsor Name:Medizinische Universitaet Wien, Univ.Klinik f.Innere Medizin III, Abteilung fuer Gastroenterologie und Hepatologie
    Full Title: Effects of oral and intravenous lipid load on Hepatitis C virus concentrations in serum and lipoprotein subfractions
    Medical condition: chronic hepatitis C
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: AT (Completed)
    Trial results: View results
    EudraCT Number: 2011-005456-33 Sponsor Protocol Number: Start Date*: 2012-01-26
    Sponsor Name:Med. Univ. Wien, Universitätsklinik für Kinder- und Jugendheilkunde
    Full Title: PREVENTING CHOLESTASIS IN PREMATURE INFANTS USING SMOFLIPID
    Medical condition: • To compare a mixed parenteral lipid emulsion containing fish oil (SMOFlipid®) with a soybean oil based lipid emulsion (Intralipid®) for its effect on the occurrence of parenteral nutrition associ...
    Disease:
    Population Age: Preterm newborn infants, Under 18 Gender: Male, Female
    Trial protocol: AT (Completed)
    Trial results: View results
    EudraCT Number: 2012-001551-39 Sponsor Protocol Number: 00003 Start Date*: 2012-10-10
    Sponsor Name:Per H. Rosenberg
    Full Title: Sitooko laskimoon annettu rasvaemulsio laskimoon annettua lidokaiinia? - farmakokineettinen ja neu-rofysiologinen tutkimus terveillä vapaaehtoisilla koehenkilöillä
    Medical condition: Health volunteers used.
    Disease:
    Population Age: Adults Gender: Male
    Trial protocol: FI (Completed)
    Trial results: (No results available)
    EudraCT Number: 2004-001653-28 Sponsor Protocol Number: 03/314 Start Date*: Information not available in EudraCT
    Sponsor Name:The Leeds teaching Hospitals NHS trust
    Full Title: A comparison of the effects on prostaglandin synthesis and cytokine production of an olive-oil based lipid emulsion (Clinoloeic) with a soya based emulsion (Intralipid) in newborn infnats receiving...
    Medical condition: Prematurity Parenteral nutrition
    Disease:
    Population Age: Preterm newborn infants, Newborns, Under 18 Gender: Male, Female
    Trial protocol: GB (GB - no longer in EU/EEA)
    Trial results: (No results available)
    EudraCT Number: 2004-002243-27 Sponsor Protocol Number: 305/2004 Start Date*: 2004-08-14
    Sponsor Name:Clinical Pharmacology
    Full Title: Vascular effects of peroxisome proliferator–activated receptor gamma stimulation with rosiglitazone during exogenousely elevated free fatty acid concentrations in healthy volunteers
    Medical condition: healthy
    Disease:
    Population Age: Adults Gender: Male
    Trial protocol: AT (Completed)
    Trial results: View results
    EudraCT Number: 2005-002425-31 Sponsor Protocol Number: 05-SMOF-006 Start Date*: 2007-03-19
    Sponsor Name:Fresenius Kabi Deutschland GmbH
    Full Title: A double-blind, randomised study comparing the safety and tolerance of SMOFlipid 20% and Intralipid 20% in long-term treatment with parenteral nutrition
    Medical condition: Supply of energy, essential fatty acids and omega-3 fatty acids to adults, as part of a parenteral nutrition regimen, when oral or enteral nutrition is impossible, insufficient or contra-indicated.
    Disease: Version SOC Term Classification Code Term Level
    8.1 10051284 Parenteral nutrition LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Completed) GB (Completed) DK (Completed)
    Trial results: View results
    EudraCT Number: 2008-008899-14 Sponsor Protocol Number: LWH0776 Start Date*: 2009-06-25
    Sponsor Name:Liverpool Women's NHS Foundation Trust
    Full Title: Standardised, Concentrated, Additional Macronutrients, Parenteral (SCAMP) nutrition in very preterm infants: a phase IV randomised controlled study of macronutrient intake, growth and implications ...
    Medical condition: Prematurity
    Disease:
    Population Age: Preterm newborn infants, Under 18 Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2009-016731-34 Sponsor Protocol Number: CRO1413 Start Date*: 2010-01-08
    Sponsor Name:Imperial College
    Full Title: Amino acid regimen and intravenous lipid composition in preterm parenteral nutrition: a randomised double blind controlled trial of Nutritional Evaluation and Optimisation in Neonates.
    Medical condition: Preterm birth
    Disease: Version SOC Term Classification Code Term Level
    12.0 10036594 Premature birth LLT
    Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Under 18 Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2014-003197-16 Sponsor Protocol Number: 810_OPBG_2014 Start Date*: 2014-12-10
    Sponsor Name:Bambino Gesù Children's Hospital
    Full Title: A Phase III randomized, controlled, open-label on the effects of parenteral nutrition early start to the late start in the ICU cardiac surgery
    Medical condition: Patients undergoing or awaiting palliative / corrective pediatric cardiac surgery who should receive parenteral nutrition
    Disease:
    Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18, Adults Gender: Male, Female
    Trial protocol: IT (Temporarily Halted)
    Trial results: (No results available)
    EudraCT Number: 2010-021446-21 Sponsor Protocol Number: 00001 Start Date*: 2010-12-28
    Sponsor Name:Per Rosenberg
    Full Title: Laskimonsisäisesti annetun rasvaemulsion kyky sitoa bupivakaiinia verenkierrossa
    Medical condition: The study is performed on healthy volunteers, investigating lipid resuscitation from local anesthetic intoxication.
    Disease: Version SOC Term Classification Code Term Level
    12.1 10066766 Acute drug intoxication LLT
    Population Age: Adults Gender: Male
    Trial protocol: FI (Completed)
    Trial results: (No results available)
    EudraCT Number: 2020-004402-55 Sponsor Protocol Number: 6344-001A Start Date*: 2020-11-09
    Sponsor Name:Baxter Healthcare Corporation
    Full Title: A Randomized, Double-Blind, Controlled, Clinical Trial to Evaluate the Risk of Developing Essential Fatty Acid Deficiency in Pediatric Patients, Including Neonates, Receiving Either Clinolipid (lip...
    Medical condition: Essential Fatty Acid Deficiency (EFAD)
    Disease: Version SOC Term Classification Code Term Level
    21.0 100000004861 10015486 Essential fatty acid deficiency LLT
    Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: Outside EU/EEA
    Trial results: View results
    EudraCT Number: 2013-001212-30 Sponsor Protocol Number: GW/MB/42964 Start Date*: 2013-07-04
    Sponsor Name:
    Full Title: Modulation of immune function by parenteral fish oil in patients with Crohn’s disease and high inherent Tumor Necrosis Factor-alfa production, a randomized, single blinded, cross-over study
    Medical condition: Crohn's disease
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2011-002825-22 Sponsor Protocol Number: PROPUDO Start Date*: 2011-12-29
    Sponsor Name:Hospital General Universitario de Alicante
    Full Title: Pilot, placebo-controlled, double-blind, randomized, parallel propofol effective in preventing refractory chronic migraine
    Medical condition: Refractory chronic migraine
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2009-015018-23 Sponsor Protocol Number: CACZ885H2356 Start Date*: 2009-12-21
    Sponsor Name:Novartis Pharma Services AG
    Full Title: A randomized, controlled study of ACZ885 (canakinumab) on the treatment and prevention of gout flares in patients with frequent flares for whom NSAIDs and/or colchicine are contraindicated, not tol...
    Medical condition: Treatment and prevention of gout flares in patients with frequent flares and for whom NSAIDs and/or colchicine are contraindicated, not tolerated or ineffective
    Disease: Version SOC Term Classification Code Term Level
    12.0 10018627 Gout LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed) LV (Completed) LT (Completed) SE (Completed) EE (Completed) BE (Completed) DK (Prematurely Ended)
    Trial results: View results
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Mon May 20 01:03:57 CEST 2024 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA